Global Oncology Information Systems Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Products and Services;
Solutions- Patient Information Systems and Treatment Planning Systems, and Professional ServicesBy Type;
Patient Information Systems, Treatment Planning Systems, and Task & Workflow Management SystemsBy Application;
Medical Oncology and Surgical OncologyBy End User;
Oncology Centers, Hospitals & Clinics, and Diagnostic LaboratoriesBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Oncology Information Systems Market Overview
Oncology Information Systems Market (USD Million)
Oncology Information Systems Market was valued at USD 3,196.72 million in the year 2024. The size of this market is expected to increase to USD 5,390.45 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.8%.
Global Oncology Information Systems Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 7.8 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 7.8 % |
Market Size (2024) | USD 3,196.72 Million |
Market Size (2031) | USD 5,390.45 Million |
Market Concentration | Medium |
Report Pages | 351 |
Major Players
- Varian Medical Systems
- RaySearch Laboratories
- Cerner Corp
- BrainLab
- Philips Healthcare
- Prowess Inc
- DOSIsoft S.A
- ViewRay Inc
- MIM Software
- Flatiron
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Oncology Information Systems Market
Fragmented - Highly competitive market without dominant players
The Oncology Information Systems (OIS) Market is experiencing notable expansion, propelled by the rising need for advanced and integrated cancer care tools. These systems are vital for enhancing patient management and optimizing treatment strategies, leading to better clinical outcomes. Currently, around 40% of cancer patients benefit from personalized therapy plans, reflecting the growing reliance on OIS for delivering targeted oncology care.
Technological Advancements Driving Efficiency
The integration of AI and data analytics into oncology platforms is a major contributor to market growth. Approximately 30% of healthcare facilities are leveraging AI-powered OIS solutions to improve diagnostic precision and streamline treatment workflows. As data volumes continue to rise, the role of smart analytics in oncology is becoming increasingly indispensable for real-time, evidence-based decisions.
Digital Transformation and Policy Support
The market is further buoyed by ongoing digital transformation in healthcare and supportive policy initiatives that encourage the integration of technology into oncology care. Nearly 50% of healthcare providers are implementing digital tools into oncology workflows, improving clinical coordination and patient safety through centralized access to real-time data and treatment records.
Outlook for Market Expansion
With continued innovations in cancer treatment technologies and a heightened focus on patient-centric solutions, the OIS market is set to grow steadily. Increased investments in healthcare IT infrastructure and the adoption of cloud-based platforms are reinforcing the importance of OIS as a backbone of effective and efficient cancer care delivery.
Oncology Information Systems Market Recent Developments
-
& Report SnapshotIn August 2021, Siemens Healthineers (Germany) completed acquisition of Varian Medical system (UK). this acquisition aimed at creation of a unique, highly integrated portfolio of oncology information system workflow.
-
In June 2021, Koninklijke Philips N.V. (The Netherlands) partnered with Elekta (Sweden) for development of advanced, comprehensive and personalized cancer care through precision oncology information solutions.
-
In December 2020, McKesson Corporation(US) has launched McKesson Corporation has launched Ontada, an oncology technology and insights business dedicated to help advance cancer research and care.
Oncology Information Systems Market Segment Analysis
In this report, the Oncology Information Systems Market has been segmented by Products & Services, Application, Type, End User and Geography.
Oncology Information Systems Market, Segmentation by Products & Services
The Oncology Information Systems Market has been segmented by Products & Services into Solutions- Patient Information Systems and Treatment Planning Systems, and Professional Services.
Solutions – Patient Information Systems
This segment accounts for approximately 35-40% of the market, focusing on the management of clinical data, treatment histories, and patient records. These systems enhance workflow efficiency and support coordinated cancer care by integrating electronic health records (EHRs) with oncology-specific functionalities.
Solutions – Treatment Planning Systems
Contributing around 30-35% of the market, these systems are crucial for developing and optimizing radiation therapy plans tailored to individual patients. They allow for precise tumor targeting while minimizing exposure to healthy tissues, and are increasingly enhanced with AI-powered imaging and dose calculation tools.
Professional Services
This segment holds a share of approximately 25-30% and includes consulting, implementation, training, and support services. The growing complexity of oncology IT systems and demand for seamless system integration are driving the need for expert services to ensure operational efficiency and regulatory compliance.
Oncology Information Systems Market, Segmentation by Type
The Oncology Information Systems Market has been segmented by Type into Patient Information Systems, Treatment Planning Systems, and Task & Workflow Management Systems.
Patient Information Systems
This segment holds the largest market share, approximately 40-45%, as these systems are essential for managing electronic medical records (EMRs), treatment history, diagnostic data, and patient demographics. They play a critical role in ensuring data accuracy, supporting clinical decisions, and improving continuity of care across multidisciplinary oncology teams.
Treatment Planning Systems
Accounting for nearly 30-35% of the market, this segment supports the design and customization of radiation therapy plans based on tumor location, size, and patient-specific anatomy. These systems improve precision targeting, reduce radiation exposure to healthy tissues, and are increasingly integrated with advanced imaging and AI capabilities.
Task & Workflow Management Systems
This segment contributes about 20-25% of the market and focuses on streamlining clinical operations, appointment scheduling, resource allocation, and treatment tracking. These systems enhance efficiency across oncology departments and help reduce administrative burden, leading to better patient outcomes and staff coordination.
Oncology Information Systems Market, Segmentation by Application
The Oncology Information Systems Market has been segmented by Application into Medical Oncology and Surgical Oncology.
Medical Oncology
This segment dominates the market with a share of approximately 60-65%, driven by the rising use of systemic therapies such as chemotherapy, immunotherapy, and targeted drugs. These systems help manage drug regimens, monitor adverse events, and support evidence-based treatment decisions, making them essential in managing complex cancer cases.
Surgical Oncology
Accounting for nearly 35-40% of the market, this segment supports preoperative planning, surgical documentation, and postoperative tracking. These systems are increasingly used to enhance care coordination between surgical teams and oncology departments, improving workflow efficiency and patient outcomes.
Oncology Information Systems Market, Segmentation by End User
The Oncology Information Systems Market has been segmented by End User into Oncology Centers, Hospitals & Clinics and Diagnostic Laboratories.
Oncology Centers
This segment holds the largest share of approximately 40-45%, as these specialized centers rely heavily on integrated oncology information systems to manage complex treatment workflows. These systems support multidisciplinary care coordination, clinical documentation, and treatment monitoring, making them critical for comprehensive cancer care delivery.
Hospitals & Clinics
Contributing around 35-40% of the market, this segment benefits from the growing adoption of electronic health records (EHRs) and treatment planning software in both public and private healthcare institutions. Integration of oncology systems within broader hospital networks improves data sharing and enhances patient care continuity.
Diagnostic Laboratories
Accounting for about 15-20% of the market, diagnostic labs use these systems to manage molecular test data, biopsy results, and pathology reporting. Seamless data exchange between labs and oncology departments ensures accurate diagnostics and supports timely treatment planning.
Oncology Information Systems Market, Segmentation by Geography
In this report, the Oncology Information Systems Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Oncology Information Systems Market Share (%), by Geographical Region
North America
This region dominates the global market with a share of approximately 40-45%, driven by strong adoption of health IT infrastructure, widespread use of electronic health records (EHRs), and the presence of leading oncology care providers. Supportive government initiatives and high investment in cancer informatics continue to bolster growth.
Europe
Europe holds a significant share of around 25-30%, fueled by expanding cancer care networks, increasing adoption of clinical decision support systems, and robust regulatory support for data interoperability. Countries like Germany, the UK, and France are leading in implementing integrated oncology solutions within national healthcare systems.
Asia Pacific
This fast-growing region accounts for approximately 20-25% of the market, supported by rising cancer incidence, increasing investments in digital health infrastructure, and government-led initiatives to modernize oncology services. Countries such as China, India, and Japan are embracing oncology information systems to enhance care delivery and improve patient outcomes.
Middle East & Africa
Contributing around 5-7% of the global market, this region is gradually adopting oncology information systems amid growing investments in specialty care centers and medical digitization. While adoption remains limited in several areas, the Gulf countries are showing strong potential due to their advanced hospital infrastructure.
Latin America
This region represents approximately 5-8% of the market. Growth is supported by increasing efforts to implement electronic medical records, improve cancer registry systems, and expand access to specialized oncology care. Brazil and Mexico are leading the way through partnerships with international health IT vendors.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Oncology Information Systems Market. These factors include; Market Drivers, Restraints and Opportunities.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing incidence of cancer worldwide
- Growing adoption of electronic health records (EHR) in oncology
-
Technological advancements in oncology information systems -Technological advancements in oncology information systems are playing a pivotal role in driving the growth of the global oncology information systems market. Modern platforms now integrate features such as electronic health records (EHR), treatment planning, real-time data analytics, and decision support tools that enable personalized and efficient cancer care. These innovations enhance communication among multidisciplinary teams, improve workflow automation, and support better clinical decision-making.
The integration of artificial intelligence (AI), machine learning, and cloud-based solutions is also transforming the way oncology data is collected, stored, and analyzed. These technologies enable more accurate outcome tracking, streamlined administrative processes, and predictive modeling for treatment efficacy. As the demand for data-driven and patient-centric oncology care rises, these technological advancements are expected to further accelerate market adoption across hospitals, cancer centers, and research institutions.
Restraints
- High cost of implementation and maintenance
- Concerns regarding data security and privacy
-
Integration challenges with existing healthcare IT infrastructure - Integration challenges with existing healthcare IT infrastructure present a significant restraint to the growth of the oncology information systems market. Many healthcare facilities operate on outdated or fragmented IT systems that lack compatibility with modern oncology platforms. This creates technical difficulties in synchronizing patient records, imaging systems, and treatment planning tools, which can disrupt workflows and compromise data accuracy.
In addition, integrating oncology systems with broader hospital networks requires substantial investment, specialized IT expertise, and ongoing maintenance. For smaller or resource-limited healthcare providers, these barriers often delay implementation or limit system functionality. Without seamless interoperability, the full benefits of oncology information systems—such as real-time collaboration and comprehensive patient management—remain difficult to achieve, thereby hindering widespread adoption.
Opportunities
- Rising demand for integrated cancer care solutions
- Expansion of oncology services in emerging markets
-
Collaborative initiatives for interoperability and data sharing - Growing collaborative initiatives for interoperability and data sharing present a major opportunity for the expansion of the oncology information systems market. Healthcare institutions, technology providers, and regulatory bodies are increasingly working together to create integrated ecosystems that enable seamless exchange of oncology-related data. These initiatives aim to break down silos between systems, allowing providers to access complete and accurate patient histories across care settings.
Standardization efforts, such as the adoption of FHIR (Fast Healthcare Interoperability Resources) and HL7 protocols, are making it easier to link oncology platforms with electronic health records, lab systems, imaging tools, and genomic databases. By improving system compatibility, these collaborative frameworks enhance clinical decision-making, reduce redundancies, and ensure continuity of care. Interoperable systems also support population health analytics and long-term outcome tracking in oncology patients.
Public-private partnerships and government-backed health information exchanges are further accelerating progress toward universal data integration. These models enable secure, real-time data flow while maintaining strict compliance with data privacy regulations. As interoperability becomes a core priority, vendors that align their oncology platforms with open architecture and cross-platform functionality are well-positioned to capture emerging market demand.
Competitive Landscape Analysis
Key players in Global Oncology Information Systems Market include:
- Varian Medical Systems
- RaySearch Laboratories
- Cerner Corp
- BrainLab
- Philips Healthcare
- Prowess Inc
- DOSIsoft S.A
- ViewRay Inc
- MIM Software
- Flatiron
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Products & Services
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Oncology Information Systems Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing incidence of cancer worldwide
-
Growing adoption of electronic health records (EHR) in oncology
-
Technological advancements in oncology information systems
-
- Restraints
-
High cost of implementation and maintenance
-
Concerns regarding data security and privacy
-
Integration challenges with existing healthcare IT infrastructure
-
- Opportunities
-
Rising demand for integrated cancer care solutions
-
Expansion of oncology services in emerging markets
-
Collaborative initiatives for interoperability and data sharing
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Oncology Information Systems Market, By Products & Services, 2021 - 2031 (USD Million)
-
Solutions
-
Patient Information Systems
-
Treatment Planning Systems
-
-
Professional Services
-
- Global Oncology Information Systems Market, By Type, 2021 - 2031 (USD Million)
- Patient Information Systems
- Treatment Planning Systems
- Task & Workflow Management Systems
-
Global Oncology Information Systems Market, By Application, 2021 - 2031 (USD Million)
-
Medical Oncology
-
Surgical Oncology
-
- Global Oncology Information Systems Market, By End User, 2021 - 2031 (USD Million)
- Oncology Centers
- Hospitals & Clinics
- Diagnostic Laboratories
- Global Oncology Information Systems Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Oncology Information Systems Market, By Products & Services, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Varian Medical Systems
- RaySearch Laboratories
- Cerner Corp
- BrainLab
- Philips Healthcare
- Prowess Inc
- DOSIsoft S.A
- ViewRay Inc
- MIM Software
- Flatiron
- Company Profiles
- Analyst Views
- Future Outlook of the Market